FAST SKELETAL REGULATORY ACTIVATOR AGREEMENTRegulatory Activator Agreement • August 10th, 2020 • Cytokinetics Inc • Pharmaceutical preparations
This Fast Skeletal Regulatory Activator Agreement (this “Agreement”) is entered into on April 23, 2020 (the “Effective Date”) by and between Cytokinetics, Inc., a corporation organized and existing under the laws of Delaware, having its principal place of business at 280 East Grand Avenue, South San Francisco, CA 94080, USA (“Cytokinetics”), and Astellas Pharma Inc., a corporation organized and existing under the laws of Japan, having its registered office at 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”). Astellas and Cytokinetics are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
License and Collaboration Agreement for Other Skeletal Sarcomere Activators by and between Cytokinetics, Inc. and Astellas Pharma Inc.License and Collaboration Agreement • August 10th, 2020 • Cytokinetics Inc • Pharmaceutical preparations
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.
